Scheduled Maintenance Notice

Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.

Select Publications

Conference Abstracts

Thistlethwaite F; Roda D; Alvarez EC; Moreno V; Guerrero TH; García-Corbacho J; Liu J; Jain VK; Calvo E; Korakis I; Ouali K; De La Motte Rouge T; Plummer R; Ottensmeier CHH; Cassier PA; Symeonides SN; Hyland N; McAlpine C; Palmer T; Lillie T, 2026, 'EMITT-1: Clinical and pharmacodynamic activity with the oral ERAP1 inhibitor GRWD5769 and cemiplimab in 6 completed phase 1b expansion cohorts in solid tumors with anti–PD-1 resistance or MSS-CRC.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 44, pp. 2500 - 2500, http://dx.doi.org/10.1200/jco.2026.44.16_suppl.2500

Liu J; Cosman R; Childs S; Cohen JE; Rodrigues A; Hansen T; Kiely BE; Chen J; Pala A; Sandhu G; Ho J; Warakulasuriya S; Elgundi D; Sim H-W; Kent R; Martin C; Woodson EM; Chaffer CL; Dear R, 2026, 'Abstract CT043: Androgen receptor inhibition to overcome taxane resistance in AR-positive metastatic TNBC: Interim results of the 4CAST Phase 1b trial', in Cancer Research, American Association for Cancer Research (AACR), Vol. 86, pp. ct043 - ct043, http://dx.doi.org/10.1158/1538-7445.am2026-ct043

Tarhini AA; Chen M; Liu J; Monga V; Atkinson V; Piha-Paul SA; Chmielowski B; Herzberg B; Lemech C; Bhave P; Kichenadasse G; Falchook G; Mehnert J; Vandross A; Salkeni M; McKean M; Wages D; Kennedy AM; Ryan MB; Clark J; Nanah A; Fossler MJ; Komarnitsky P; Puzanov I, 2026, 'Abstract CT129: Preliminary results from a Phase 1a/b dose-escalation and expansion trial of the pan-RAF-MEK molecular glue NST-628 in patients (pts) with advanced or refractory RAF, KRAS, and NRAS-mutant solid tumors', in Cancer Research, American Association for Cancer Research (AACR), Vol. 86, pp. ct129 - ct129, http://dx.doi.org/10.1158/1538-7445.am2026-ct129

Liu J; Frentzas S; Kichenadasse G; Price T; Tebbutt N; Mendis S; Al-Asady R; Hsu E; Chan M; Tran P; Shafren D; Zdanska O; Wong M, 2026, 'Abstract CT183: Phase Ib clinical evaluation of a novel CD55- and FcRn-bioselected RNA oncolytic virus, IVX037, combined with sintilimab (anti-PD-1) in advanced microsatellite-stable colorectal cancer', in Cancer Research, American Association for Cancer Research (AACR), Vol. 86, pp. ct183 - ct183, http://dx.doi.org/10.1158/1538-7445.am2026-ct183

Hollebecque A; Borad MJ; Lu P; Meng X; Ryan K; Alexander L; Liu J; Oh D-Y; Kim RD, 2026, 'Efficacy and safety of lirafugratinib in FGFRi-naïve cholangiocarcinoma (CCA) patients harboring FGFR2 fusions/rearrangements (FGFR2 f/r).', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 44, pp. 476 - 476, http://dx.doi.org/10.1200/jco.2026.44.2_suppl.476

Hall A; Crumbaker M; Pham J; Liu J; Sim HW; Joshua AM, 2024, 'A meta-analysis of overall survival and response in metastatic adrenocortical carcinoma: A review of 23 prospective trials of 880 patients.', in Journal of Clinical Oncology, Vol. 42, pp. 4 - 4, http://dx.doi.org/10.1200/JCO.2024.42.4_suppl.4

Pinato DJ; Jones RH; Forster MD; Joshua AM; Korolewicz J; Benafif S; Aboud K; Liu JJ; Cosman R; Paull J; Fairley J; Edmondson SR; Spicer JF, 2024, 'Efficacy and safety of dendrimer-enhanced (DEP) cabazitaxel (CTX-SPL9111) in advanced esophagogastric cancers in a phase 1/2 trial', in Journal of Clinical Oncology, Vol. 42, http://dx.doi.org/10.1200/JCO.2024.42.3_suppl.374

Hurwitz J; Nindra U; Liu J, 2022, 'Systematic review of neoadjuvant and definitive immunotherapy in head and neck squamous cell carcinoma', in Asia-Pacific Journal of Clinical Oncology, Wiley, Vol. 18, pp. 38 - 38, presented at Medical Oncology Group of Australia Incorporated Annual Scientific Meeting 2022, https://doi.org/10.1111/ajco.13856

Zdanska O; Zdansky P; Liu J; Joshua A; Stanners M; Rogers C, 2022, 'Patient experiences of prolonged living with cancer during early phase trial treatment', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 147 - 147

Parmar J; Aggarwal N; Zdanska O; Yousif J; Hurwitz J; Handel E; Rodrigues A; Prawira A; Joshua A; Cosman R; Liu J, 2022, 'Telehealth maintains access to early phase clinical trials during the Covid-19 pandemic', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 154 - 155

Liu JJ; Zhang M; Rose B; Veillard A-S; Jones D; Lee S; Hong A, 2014, 'KI67 EXPRESSION HAS PROGNOSTIC SIGNIFICANCE IN RELATION TO HUMAN PAPILLOMAVIRUS STATUS IN OROPHARYNGEAL SQUAMOUS CELL CARCINOMA', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 10, pp. 180 - 181, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000345350900317&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Liu J; Hesson LB; Meagher AP; Bourke MJ; Hawkins NJ; Rand KN; Molloy PL; Pimanda JE; Ward RL, 2012, 'Abstract 3125: Relative distribution of folate species is associated with global DNA methylation in human colorectal mucosa', in Cancer Research, American Association for Cancer Research (AACR), Vol. 72, pp. 3125 - 3125, http://dx.doi.org/10.1158/1538-7445.am2012-3125


Back to profile page